TITLE

proton pump

PUB. DATE
January 2005
SOURCE
Taber's Cyclopedic Medical Dictionary;2005, p1796
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
The article presents definition of the term proton pump, which means an enzyme which is located in stomach's parietal cell that discharges hydrogen ions in exchange for potassium ions. Hydrogen/potassium adenosine triphosphate is the formal name of protein pump.
ACCESSION #
21242527

 

Related Articles

  • Esophageal Acid Exposure Decreases Intraluminal Baseline Impedance Levels. Kessing, Boudewijn F; Bredenoord, Albert J; Weijenborg, Pim W; Hemmink, Gerrit J M; Loots, Clara M; Smout, A J P M // American Journal of Gastroenterology;Dec2011, Vol. 106 Issue 12, p2093 

    OBJECTIVES:Intraluminal baseline impedance levels are determined by the conductivity of the esophageal wall and can be decreased in gastroesophageal reflux disease (GERD) patients. The aim of this study was to investigate the baseline impedance in GERD patients, on and off proton pump inhibitor...

  • Intravenous Lansoprazole: A Viewpoint by Neville Yeomans. Yeomans, Neville // Drugs;2004, Vol. 64 Issue 18, p2090 

    The intravenous proton pump inhibitor, lansoprazole, is useful for patients who cannot take oral preparations. It is also used for obtaining rapid control of gastric activity in high-risk patients with bleeding peptic ulcers. Studies have shown that intravenous lansoprazole has similar to...

  • Esophageal pH-Impedance Monitoring in Patients With Therapy-Resistant Reflux Symptoms: ‘On’ or ‘Off’ Proton Pump Inhibitor? Hemmink, Gerrit J. M.; Bredenoord, Albert J.; Weusten, Bas L. A. M.; Monkelbaan, Jan F.; Timmer, Robin; Smout, André J. P. M. // American Journal of Gastroenterology;Oct2008, Vol. 103 Issue 10, p2446 

    BACKGROUND: In patients with proton pump inhibitor (PPI)-resistant symptoms, ambulatory 24-h pH-impedance monitoring can be used to assess whether a relationship exists between symptoms and reflux episodes. Until now, it is unclear whether combined pH-impedance monitoring in these patients...

  • Addition of Esophageal Impedance Monitoring to pH Monitoring Increases the Yield of Symptom Association Analysis in Patients off PPI Therapy. Bredenoord, Albert J.; Weusten, Bas L. A. M.; Timmer, Robin; Conchillo, José M.; Smout, André J. P. M. // American Journal of Gastroenterology;Mar2006, Vol. 101 Issue 3, p453 

    BACKGROUND: The additional yield of esophageal impedance monitoring in identification of reflux as the cause of reflux symptoms is unknown. OBJECTIVES: To compare the yield of symptom–reflux association analysis of combined esophageal pH-impedance data with the yield of analysis of pH...

  • Diagnostic and Therapeutic Use of Proton Pump Inhibitors in Non-Cardiac Chest Pain: A Metaanalysis. Cremonini, Filippo; Wise, James; Moayyedi, Paul; Talley, Nicholas J. // American Journal of Gastroenterology;Jun2005, Vol. 100 Issue 6, p1226 

    OBJECTIVES: To assess (i) the efficacy of short-term proton pump inhibitors (PPIs) in non-cardiac chest pain (NCCP) and (ii) the performance of an empirical short-term treatment with PPI (PPI test) to establish a diagnosis of abnormal acid reflux in NCCP.METHODS: Metaanalysis of English language...

  • Inhibition of lysosomal enzyme activities by proton pump inhibitors. Liu, Wensheng; Baker, Susan; Trinidad, Jonathan; Burlingame, Alma; Baker, Robert; Forte, John; Virtuoso, Lauren; Egilmez, Nejat; Zhu, Lixin // Journal of Gastroenterology;Dec2013, Vol. 48 Issue 12, p1343 

    Background: Proton pump inhibitors (PPIs) are pro-drugs requiring an acidic pH for activation. The specificity of PPI toward the proton pump is mainly due to the extremely low pH at the parietal cell canalicular membrane where the pump is located. Reactivity of PPIs was also observed in...

  • Proton Pump Inhibitors and Acid Pump Antagonists. Jai Moo Shin; Wallmark, Björn; Sachs, George // Encyclopedic Reference of Molecular Pharmacology;2004, p771 

    The article presents an encyclopedia entry for proton pump inhibitors and acid pump antagonists. It can be classified into reversible and non-reversible covalent inhibitors. The covalent binding inhibitors are substituted 2-benzimidazoles and the reversible inhibitors are K+-competitive. The PPI...

  • Reflux Revisited: Advancing the Role of Pepsin. Bardhan, Karna Dev; Strugala, Vicki; Dettmar, Peter W. // International Journal of Otolaryngology;2012, p1 

    Gastroesophageal reflux disease is mediated principally by acid. Today, we recognise reflux reaches beyond the esophagus, where pepsin, not acid, causes damage. Extraesophageal reflux occurs both as liquid and probably aerosol, the latter with a further reach. Pepsin is stable up to pH 7 and...

  • Proton Pump Inhibitors: An Update. Vanderhoff, Bruce T.; Tahboub, Rundsarah M. // American Family Physician;7/15/2002, Vol. 66 Issue 2, p273 

    Presents an update on proton pump inhibitors. Pharmacology; Side effects and precautions; Dosage and administration.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics